2009China Practical MedicineRequires access

A clinical study of monosialotetrahexosylganglioside(GM1) injection’s curative effect on acute cerebral infarction

Deng Yao-fang

Open publisher page 0 citations

Abstract

Objective To evaluate the curative effect of GM-1 injection on acute cerebral infarction. Methods Total 152 patients with acute cerebral infarction were randomly divided into two group:the treatment group and control group. The treatment group were treated with GM-1 (40 mg per day for 21 days) and the control group were treated with citicoline (0.75 per day for 21 day).Results There was significant difference in the total effective rate between the treatment group(84.2%) and the control group(65.6%)(P0.05). Conclusion The patients with acute cerebral infarction during the early period should be treated with GM-1,which will speed the recovery of neurological function and improve the quality of life.

About this research paper

What this paper is about

Objective To evaluate the curative effect of GM-1 injection on acute cerebral infarction. Methods Total 152 patients with acute cerebral infarction were randomly divided into two group:the treatment group and control group. The treatment group were treated with GM-1 (40 mg per day for 21 days) and the control group were treated with citicoline (0.75 per day for 21 day).Results There was significant difference in the total effective rate between the treatment group(84.2%) and the control group(65.6%)(P0.05). Conclusion The patients with acute cerebral infarction during the early period should be treated with GM-1,which will speed the recovery of neurological function and improve the quality of life.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the curative effect of GM-1 injection on acute cerebral infarction. Methods Total 152 patients with acute cerebral infarction were randomly divided into two group:the treatment group and control group. The treatment group were treated with GM-1 (40 mg per day for 21 days) and the control group were treated with citicoline (0.75 per day for 21 day).Results There was significant difference in the total effective rate between the treatment group(84.2%) and the control group(65.6%)(P0.05). Conclusion The patients with acute cerebral infarction during the early period should be treated with GM-1,which will speed the recovery of neurological function and improve the quality of life.

Key concepts: Medicine, Citicoline, Cerebral infarction, Anesthesia, Treatment and control groups, Significant difference, Brain infarction, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
A clinical study of monosialotetrahexosylganglioside(GM1) injection’s curative effect on acute cerebral infarction — Research Paper | ScholarLens